Fair value (multi-method)
Four independent methods triangulate what CME is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$860.37
Method range
$69.26 – $860.37
median $288.90
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $860.37 | +245.20% |
| Exit multiple | $274.47 | +10.12% |
| Analyst target | $303.33 | +21.70% |
| Graham number | $69.26 | -72.21% |
- Forward DCF$860.37
- Exit multiple$274.47
- Analyst target$303.33
- Graham number$69.26
Stock price
$249.24
EPS (TTM)
$11.79
5Y EPS CAGR
13.7%
Fair value @ hist. growth
$860.37
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied EPS growth
-1.2%
per year over your projection horizon
Margin of safety 71.0% vs hist-growth DCF
Historical 5Y CAGR
13.7%
Your model implies
-1.2%
Next-year analyst consensus
3.0%
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | -2.2% | -3.5% | -5.0% | -6.8% | -9.1% |
| 5.0% | -2.1% | -3.3% | -4.8% | -6.6% | -8.8% |
| 6.1% | 0.8% | -0.1% | -1.2% | -2.5% | -3.9% |
| 7.1% | 3.3% | 2.6% | 1.7% | 0.7% | -0.3% |
| 8.1% | 5.6% | 4.9% | 4.2% | 3.5% | 2.6% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net cash
$666M
Total debt − cash
Beta
0.28
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.78% TTM
- Dividend Profile4.51% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.